Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$229,964
-$50,190 QoQ
Shares Held
9,550
-4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,338
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
This page
|
9,550 | $229,964 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,964 | 9,550 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $280,154 | 9,977 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $284,955 | 11,444 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $241,600 | 9,967 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $211,512 | 8,347 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $214,707 | 8,093 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $218,699 | 7,557 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $243,621 | 8,707 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $234,681 | 8,457 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $444,488 | 15,439 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $511,779 | 15,429 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $546,495 | 14,899 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $645,374 | 15,818 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $771,469 | 15,056 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $632,594 | 14,456 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $757,928 | 14,456 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $754,340 | 14,571 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $863,133 | 14,617 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $612,075 | 14,231 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $596,445 | 15,231 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $557,797 | 15,396 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $536,284 | 14,569 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $486,274 | 13,250 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $412,053 | 12,601 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $411,296 | 12,601 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||